Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Got $500? 3 Top TSX Dividend Stocks to Buy Now

Published 2022-03-24, 02:17 p/m
© Reuters.  Got $500? 3 Top TSX Dividend Stocks to Buy Now
IMOB
-

People with limited funds can be like high-net-worth individuals who don’t keep their cash idle. Instead of spending $500 on needless things, you can grow the money through dividend investing. There are inexpensive, profitable investment options on the TSX.

Three dividend stocks trade below $10, but their dividend yields are between 7% and 8.5%, above market average. Because of their high yields, they are ideal holdings in a tax-advantaged account like a TFSA.

Resilient business model Investors in Inovalis (TSX:INO.UN) gain exposure to the real estate market in Europe, particularly the office sub-sector. This $303.59 million real estate investment trust (REIT) owns and leases office properties in France and Germany. As of this writing, the share price is $9.82, while the dividend yield is a fantastic 8.40%.

Inovalis President Stéphane Amine said, “The resilience of our business model, investing in European offices in strategic locations, has proven itself throughout the pandemic, and gives us great confidence for the future.” The full-year 2021 results aren’t out yet, but the financial results in the three first quarters were solid.

High-quality tenants comprise 84.9% of the total portfolio on an occupancy rate of 82.2%. On February 2, 2022, the French government ended the mandatory work-from-home directive. In Germany, the end of the working from home obligation was March 20, 2021.

Strong fundamentals Chemtrade Logistics (TSX:CHE.UN) is popular with income investors due to its consistently high yield. If you invest today ($8.07 per share), the dividend offer is 7.43%. The $845.24 million company is a provider of industrial chemicals and related services, and the reach is global.

In North America, Chemtrade is one of the largest suppliers of sulphuric acid. In international markets, it offers inorganic coagulants for water treatment, sodium chlorate, sodium nitrite, sodium hydrosulphite, and phosphorus pentasulphide. The global pandemic hurt the business last year, but the outlook for 2022 is favourable.

In 2021, net loss widened 40.4% to $235.2 million versus 2020. Nevertheless, Chemtrade President and CEO Scott Rook said, “2021 ended on a much stronger note than it started.” He adds that management significantly strengthened the balance sheet during the year.

Rook notes the strong fundamentals for several key products in Chemtrade’s portfolio entering 2022. The plan is to pursue exciting organic growth opportunities in ultra-pure sulphuric acid and byproduct green hydrogen.

Progress in 2022 Timbercreek Financial (TSX:TF) provides shorter-duration (less than five years) structured financing solutions to commercial real estate professionals. This $793.41 million non-bank lender maintains a conservative credit policy to ensure strong risk-adjusted yields for investors.

In 2021, Timbercreek’s net income rose 29.1% to $41.3 million versus 2020. The conservative portfolio risk position was evident in Q4 2021. About 93.2% of the mortgage investment portfolio are first mortgages, while 88.3% of the investments are in cash-flowing properties. Moreover, the weighted average loan-to-value is 70.1%.

Blair Tamblyn, Timbercreek’s CEO, said, “We expect further progress in 2022, which will allow us to reinvest this capital in mortgages that will be accretive to distributable income.” TF trades at $9.68 per share and pays a 7.14% dividend.

Great value Inovalis, Chemtrade, and Timbercreek are steady performers amid the market volatility. While the businesses have inherent risks, the dividend stocks are great value buys at their current share prices.

The post Got $500? 3 Top TSX Dividend Stocks to Buy Now appeared first on The Motley Fool Canada.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool recommends Inovalis REIT.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.